Significance of native PLGA nanoparticles in the treatment of Alzheimer's disease pathology

Alzheimer's disease (AD) is believed to be triggered by increased levels/aggregation of β-amyloid (Aβ) peptides. At present, there is no effective disease-modifying treatment for AD. Here, we evaluated the therapeutic potential of FDA-approved native poly(d,l-lactide-co-glycolide) (PLGA) nanopa...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Bibin, Wu, Qi, Nakhaei-Nejad, Maryam, Karthivashan, Govindarajan, Dorosh, Lyudmyla, Amidian, Sara, Dahal, Abhishek, Li, Xiuju, Stepanova, Maria, Wille, Holger, Giuliani, Fabrizio, Kar, Satyabrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614411/
https://www.ncbi.nlm.nih.gov/pubmed/36330076
http://dx.doi.org/10.1016/j.bioactmat.2022.05.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614411/
https://www.ncbi.nlm.nih.gov/pubmed/36330076
http://dx.doi.org/10.1016/j.bioactmat.2022.05.030

Ejemplares similares